Britain’s Pfizer Vaccine:
Britain’s Medicines and Healthcare Products Regulatory Agency (MHRA) became the first nation in the world to approve the corona aka Covid-19 vaccine last week. The vaccine is developed by Germany’s BioNTech and Pfizer. The U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) are still assessing the data for the trial.
The Medicines and Healthcare Products Regulatory Agency (MHRA) said there had been two reports of anaphylaxis and one report of a possible allergic reaction since the rollout began. MHRA Chief Executive June Raine has issued following statement:
“Any person with a history of anaphylaxis to a vaccine, medicine or food should not receive the Pfizer BioNTech vaccine ……….. Most people will not get anaphylaxis and the benefits in protecting people against COVID-19 outweigh the risks… You can be completely confident that this vaccine has met the MHRA’s robust standards of safety, quality and effectiveness.”